Anika Therapeutics (ANIK) News Today $16.62 -0.32 (-1.89%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest UpdateAnika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 367,500 shares, a decline of 27.8% from the November 15th total of 508,900 shares. Based on an average daily volume of 92,800 shares, the days-to-cover ratio is currently 4.0 days. Currently, 2.6% of the shares of the stock are sold short.December 13, 2024 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Sees Significant Growth in Short InterestAnika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 508,900 shares, a growth of 5.1% from the October 31st total of 484,400 shares. Currently, 3.6% of the shares of the stock are sold short. Based on an average daily volume of 85,500 shares, the days-to-cover ratio is presently 6.0 days.December 3, 2024 | marketbeat.comAnika To Participate in December 2024 Investor ConferencesNovember 22, 2024 | globenewswire.comAnika Therapeutics Navigates Geopolitical Risks Amid Global ConflictsNovember 7, 2024 | markets.businessinsider.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Capital Management Corp VACapital Management Corp VA trimmed its position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 11.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 290,350 shares of thNovember 5, 2024 | marketbeat.comAnika Therapeutics (NASDAQ:ANIK) Downgraded to Hold Rating by StockNews.comStockNews.com downgraded Anika Therapeutics from a "buy" rating to a "hold" rating in a research note on Monday.November 4, 2024 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | msn.comAnika Therapeutics price target lowered to $25 from $37 at BarringtonNovember 3, 2024 | markets.businessinsider.comAnika (ANIK) Earnings Dates & ReportsNovember 3, 2024 | investing.comAnika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call TranscriptNovember 2, 2024 | seekingalpha.comAnika Therapeutics Third Quarter 2024 Earnings: Misses ExpectationsNovember 2, 2024 | finance.yahoo.comRetail Investors Remain Cautious After Anika’s Q3 Earnings Misses EstimatesNovember 2, 2024 | msn.comOptimistic Buy Rating for Anika Therapeutics Amidst Recent Setbacks and Strategic Growth ProspectsNovember 2, 2024 | markets.businessinsider.comBarrington Research Issues Pessimistic Forecast for Anika Therapeutics (NASDAQ:ANIK) Stock PriceBarrington Research dropped their price objective on Anika Therapeutics from $37.00 to $25.00 and set an "outperform" rating for the company in a report on Friday.November 1, 2024 | marketbeat.comAnika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 1, 2024 | finance.yahoo.comAnika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ...November 1, 2024 | finance.yahoo.comAnika Therapeutics Focuses on Core Growth Amid RestructuringNovember 1, 2024 | tipranks.comAnika Therapeutics Inc.: Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus MedicalOctober 31, 2024 | finanznachrichten.deAnika Therapeutics Inc.: Anika Reports Third Quarter 2024 Financial ResultsOctober 31, 2024 | finanznachrichten.deArthrosurface Returns to it Roots Following Divestiture from Anika TherapeuticsOctober 31, 2024 | finance.yahoo.comAnika Therapeutics announces Arthrosurface sale, plan to divest Parcus MedicalOctober 31, 2024 | markets.businessinsider.comWhat's Next: Anika Therapeutics's Earnings PreviewOctober 31, 2024 | benzinga.comInvestors in Anika Therapeutics (NASDAQ:ANIK) have unfortunately lost 61% over the last five yearsOctober 31, 2024 | finance.yahoo.comAnika Reports Third Quarter 2024 Financial ResultsOctober 31, 2024 | globenewswire.comAnika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus MedicalOctober 31, 2024 | globenewswire.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Sees Significant Decline in Short InterestAnika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) saw a large drop in short interest in October. As of October 15th, there was short interest totalling 489,100 shares, a drop of 23.5% from the September 30th total of 639,300 shares. Currently, 3.4% of the company's stock are sold short. Based on an average trading volume of 49,200 shares, the short-interest ratio is presently 9.9 days.October 27, 2024 | marketbeat.comRiverwater Partners LLC Has $2.55 Million Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK)Riverwater Partners LLC raised its stake in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 539.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 101,996 shares of the biotechnology company's stock after acquiriOctober 24, 2024 | marketbeat.comAnika Therapeutics (ANIK) Set to Announce Earnings on ThursdayAnika Therapeutics (NASDAQ:ANIK) will be releasing earnings before the market opens on Thursday, October 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636929)October 24, 2024 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Chromadex (CDXC), Anika Therapeutics (ANIK)October 23, 2024 | markets.businessinsider.comAnika Therapeutics (NASDAQ:ANIK) Rating Reiterated by Barrington ResearchBarrington Research reaffirmed an "outperform" rating and set a $37.00 price target on shares of Anika Therapeutics in a research note on Tuesday.October 22, 2024 | marketbeat.comAnika Announces Third Quarter 2024 Results Conference Call DateOctober 17, 2024 | globenewswire.comShort Interest in Anika Therapeutics, Inc. (NASDAQ:ANIK) Drops By 5.0%Anika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) saw a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 639,300 shares, a decline of 5.0% from the September 15th total of 673,300 shares. Based on an average daily trading volume, of 50,200 shares, the days-to-cover ratio is currently 12.7 days. Currently, 4.5% of the shares of the company are short sold.October 17, 2024 | marketbeat.comTesla shares fall in premarket trading after Cybercab introductionOctober 12, 2024 | msn.comAnika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...October 9, 2024 | finance.yahoo.comSquarepoint Ops LLC Sells 30,809 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)Squarepoint Ops LLC decreased its stake in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 58.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,648 shares of the biotechnology company's stock after sellingOctober 9, 2024 | marketbeat.comChronic Pain Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsightOctober 7, 2024 | theglobeandmail.comAldeyra Therapeutics (NASDAQ:ALDX) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comDimensional Fund Advisors LP Sells 60,471 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)Dimensional Fund Advisors LP trimmed its stake in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 7.5% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 749,284 shares of the biotechnology company's stock after selling 60,471 shOctober 5, 2024 | marketbeat.comAnika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 4, 2024 | globenewswire.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Stonepine Capital Management LLCStonepine Capital Management LLC increased its stake in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 171.4% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 165,397 shares of the biotechnology company's stock after acquOctober 1, 2024 | marketbeat.comMeros Investment Management LP Acquires 42,587 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)Meros Investment Management LP lifted its holdings in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 25.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 212,714 shareSeptember 27, 2024 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Renaissance Technologies LLCRenaissance Technologies LLC increased its stake in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 6.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 598,229 shares of the biotechnology company's stock after pSeptember 22, 2024 | marketbeat.comAdhesion Barrier Market to Reach $1.5 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market ResearchSeptember 18, 2024 | finance.yahoo.comAnika Therapeutics Inc (ANIK) Stock Price Up 4.14% on Sep 17September 17, 2024 | gurufocus.comKids make Elliot Avenue Gazette front page newsSeptember 17, 2024 | msn.comAcadian Asset Management LLC Purchases 21,517 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)Acadian Asset Management LLC grew its position in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 5.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 442,944 shares of the biotechnology company's stock after buying an additional 21,517 shares duringSeptember 10, 2024 | marketbeat.comAnika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 9, 2024 | globenewswire.comAnika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200-Day Moving Average of $25.90Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above 200 Day Moving Average of $25.90September 3, 2024 | marketbeat.comAnika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 15, 2024 | globenewswire.comGlobal Non-Steroidal Anti-Inflammatory Drugs Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2030 | DelveInsightAugust 15, 2024 | finance.yahoo.com Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Forbes rich list released… #1 to be assassinated? (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies. To get the full details on the fake “energy crisis” of America, watch this now ANIK Media Mentions By Week ANIK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIK News Sentiment▼1.610.79▲Average Medical News Sentiment ANIK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIK Articles This Week▼22▲ANIK Articles Average Week Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cerus News OraSure Technologies News Utah Medical Products News West Pharmaceutical Services News Cooper Companies News Align Technology News Merit Medical Systems News Haemonetics News DENTSPLY SIRONA News ICU Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIK) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
